Search by Ticker
Edwards Lifesciences Corporatio (NYSE:EW)
The following stock analysis is based on 6.9 years of data (i.e. since Sep 20, 2013). All the stock history has been downloaded.
Edwards Lifesciences Corporatio trades on the NYSE exchange in USD dollars.
It is in the healthcare sector.
It is currently trading at $76.66 ($75.78 the previous day).
The next reporting date is in 76 days (2020 10 27).
CNN estimates profits for the upcoming quarter will be $0.43 per share ($1.1B). The current Canada / US exchange rate is 1.33134.
Over the past 12 months, $0 worth of shares have been purchased and $71006046 worth of shares have been sold by insiders.
The year over year average increase is 26.0% per year assuming steady exponential growth. The actual 5 year average is 28.32. Details on the individual increase in one year intervals is provided below.
|Past Performance||Average Price||Percent Change|
|1 year||73.8363671875||30.9||+ Above Average|
|2 year||56.427620967742||32.4||+ Above Average|
|3 year||42.611715481172||22.8||- Below Average|
|4 year||34.702897959184||16.3||- Below Average|
|5 year||29.830227272727||39.2||+ Above Average|
The worst drop it has had in recent years is -36.2%. It has a steady shape to the stock curve, which means the stock continues on a consistent trend except during extreme periods of volitility, but usually recovers quickly. These stocks are very safe and do not have to be checked often.
Edwards Lifesciences is an American medical equipment company specializing in artificial heart valves and hemodynamic monitoring. It is mostly known for a transcatheter aortic heart valve made of bovine tissue within a collapsible stainless-steel stent, deployed via catheter. Their SAPIEN product is an FDA-approved device for percutaneous aortic valve replacement.
The company was founded in 1958 and has since grown to 12,200 employees and $3.4 billion in revenue by 2017. Their headquarters is located in Irvine, California (USA). The chairman and CEO is Michael A. Mussallem. The company is part of the S&P500.
Long-Term Leaders List Welcomes This Giant Software CompanyFri, 07 Aug 2020 19:03:48 IBDand's Long-Term Leaders continue to power higher as the raging bull market hits new highs. Long-Term Leader Portfolio Welcomes Salesforce.com Led by founder Marc Benioff, Salesforce.com (CRM) remains the dominant player in customer relationship management software. Since going ...... Read Full Article
TMO vs. EW: Which Stock Is the Better Value Option?Thu, 06 Aug 2020 15:40:03 TMO vs. EW: Which Stock Is the Better Value Option?... Read Full Article
Vanguard Health Care Fund Adds 3 Stocks to PortfolioFri, 31 Jul 2020 16:58:36 Fund focused on health reveals 2nd-quarter trades Continue reading...... Read Full Article
The Top 5 Trades of the Eaton Vance Worldwide Health Sciences FundMon, 27 Jul 2020 19:18:39 Health care-focused fund releases 2nd-quarter portfolio Continue reading...... Read Full Article
Edwards Inches Closer To Breakout On $100 Million Heart-Valve BeatFri, 24 Jul 2020 20:24:14 Edwards Lifesciences handily topped Wall Streetand's second-quarter expectations amid a resurgence in heart-valve replacements. EW stock inched slightly closer to a buy point Friday.... Read Full Article
P/E Ratio Insights for Edwards LifesciencesFri, 24 Jul 2020 13:48:00 In the current session, Edwards Lifesciences Inc. (NYSE: EW) is trading at $77.38, after a 0.05% rise. Over the past month, the stock increased by 20.14%, and in the past year, by 11.87%. With performance like this, long-term shareholders optimistic but others are more ...... Read Full Article
Edwards Lifesciences (EW) Beats on Q2 Earnings, Ups EPS ViewFri, 24 Jul 2020 13:22:01 Despite coronavirus-hit sales, Edwards Lifesciences (EW) witnessed steady improvement in TAVR procedure volumes in Q2. Regulatory approvals look encouraging.... Read Full Article
Edwards Lifesciences Blows Past Q2 Earnings EstimatesFri, 24 Jul 2020 10:03:00 Investors might not be overly excited about Edwards Lifesciences' (NYSE: EW) stock performance so far in 2020. Edwards Lifesciences announced its second-quarter results after the market closed on Thursday, and the stock jumped 5% in after-hours trading.... Read Full Article
Edwards Lifesciences Corp (EW) Q2 2020 Earnings Call TranscriptFri, 24 Jul 2020 02:31:19 With me on today's call are Mike Mussallem, Chairman and Chief Executive Officer and Scott Ullem Chief Financial Officer. Just after the close of regular trading, Edwards Lifesciences released second quarter 2020 financial results.... Read Full Article
Edwards Lifesciences (EW) Q2 Earnings and Revenues Beat EstimatesThu, 23 Jul 2020 21:35:09 Edwards Lifesciences (EW) delivered earnings and revenue surprises of 126.67% and 18.15%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?... Read Full Article
Edwards Lifesciences: Q2 Earnings InsightsThu, 23 Jul 2020 20:49:37 Shares of Edwards Lifesciences (NYSE:EW) moved higher by 3.5% in after-market trading after the company reported Q2 results.Quarterly Results Earnings per share decreased 75.36% year over year to $0.34, which beat the estimate of $0.17.Revenue of $925,000,000 declined by 14.90% year over year, ...... Read Full Article
Edwards Lifesciences Stares Down A Buy Point After Its Earnings BeatThu, 23 Jul 2020 20:37:53 Late Thursday, Edwards Lifesciences reported adjusted income of 34 cents per share on $925 million in sales for its second quarter ended June 30. In response, EW stock popped.... Read Full Article
Edwards Lifesciences Reports Second Quarter ResultsThu, 23 Jul 2020 20:15:00 Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended June 30, 2020.... Read Full Article
If You Own Edwards Lifesciences (EW) Stock, Should You Sell It Now?Wed, 22 Jul 2020 17:04:41 Brown Advisory recently released its Q2 2020 Investor Letter, a copy of which you can download here. The Large-Cap Growth Fund posted a return of 27.86% for the quarter, outperforming its benchmark, the Russell 1000 Growth Index which returned 27.84% in the same quarter. ...... Read Full Article
Why Earnings Season Could Be Great for Edwards Lifesciences (EW)Wed, 22 Jul 2020 12:39:12 Edwards Lifesciences (EW) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.... Read Full Article
Is Edwards Lifesciences Corporationand's(NYSE:EW) Recent Stock Performance Tethered To Its Strong Fundamentals?Mon, 20 Jul 2020 16:36:39 Most readers would already be aware that Edwards Lifesciencesand' (NYSE:EW) stock increased significantly by 9.3% over...... Read Full Article
Analysts Estimate Edwards Lifesciences (EW) to Report a Decline in Earnings: What to Look Out forThu, 16 Jul 2020 16:31:04 Edwards Lifesciences (EW) doesnand't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.... Read Full Article
Whatand's in Store for Edwards Lifesciences (EW) in Q2 Earnings?Thu, 16 Jul 2020 13:36:01 Robust customer adoption of the TruWave disposable pressure monitoring devices and INSPIRIS RESILIA aortic valve are likely to have driven Edwards Lifesciencesand' (EW) Q2 revenues.... Read Full Article
Paul LaViolette Appointed To Edwards Lifesciences Board Of DirectorsWed, 15 Jul 2020 12:30:00 Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that Paul A. LaViolette has been appointed to its board of directors. LaViolette has 40 years of experience in global ...... Read Full Article
Edwardsand' KONECT RESILIA Aortic Valved Conduit Receives FDA Approval For Complex Aortic Valve SurgeriesWed, 15 Jul 2020 12:30:00 Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced it received approval from the U.S. Food and Drug Administration (FDA) for the KONECT RESILIA aortic valved conduit (...... Read Full Article